✦ LIBER ✦

Antigen-Presenting Cells 8015 (Provenge®) in Patients with Androgen-Dependent, Biochemically Relapsed Prostate Cancer

✍ Scribed by Beinart, Garth; Rini, Brian I.; Weinberg, Vivian; Small, Eric J.

Book ID: 119935368
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 891 KB
Volume: 4
Category: Article
ISSN: 1540-0352
DOI: 10.3816/cgc.2005.n.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination immunotherapy with prostatic

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

✍ Brian I. Rini; Vivian Weinberg; Lawrence Fong; Shauna Conry; Robert M. Hershberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Thomsen-Friedenreich (TF) antigen as a t

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

✍ Susan F. Slovin; Govind Ragupathi; Cristina Musselli; Celina Fernandez; Meghan D 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 378 KB

Vaccination of prostatectomized prostate

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

✍ Benoît Barrou; Gérard Benoît; Mahmoud Ouldkaci; Olivier Cussenot; Margarita Salc 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 224 KB